Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Suk Ryu

Showing results (101-110 of 149) with videos related to

Pageof 15
Sort By:
International Journal of Molecular Sciences|November 11, 2022
Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning AlgorithmHyebin Lee, Han Suk Ryu, Hee Chul Park, et al.
International Journal of Molecular Sciences|January 27, 2024
Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive SystemIoannis S Pateras, Ana Igea, Ilias P Nikas, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2024
Immune marker expression and prognosis of early breast cancer expressing HER3Dae-Won Lee, Han Suk Ryu, Ilias P Nikas, et al.
Breast Cancer Research and Treatment|September 7, 2022
Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapySong Yi Park, Koung Jin Suh, Dae-Won Lee, et al.
Breast Cancer Research : BCR|November 26, 2020
Combined the SMAC mimetic and BCL2 inhibitor sensitizes neoadjuvant chemotherapy by targeting necrosome complexes in tyrosine aminoacyl-tRNA synthase-positive breast cancerKyung-Min Lee, Hyebin Lee, Dohyun Han, et al.
Scientific Reports|April 14, 2021
Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypassMark Borris D Aldonza, Roben D Delos Reyes, Young Seo Kim, et al.
Genome Biology|October 10, 2018
PHLI-seq: constructing and visualizing cancer genomic maps in 3D by phenotype-based high-throughput laser-aided isolation and sequencingSungsik Kim, Amos Chungwon Lee, Han-Byoel Lee, et al.
Virchows Archiv : an International Journal of Pathology|May 18, 2016
Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancerMin-Sun Jin, Hyebin Lee, In Ae Park, et al.
Cancers|November 27, 2019
Automated Gleason Scoring and Tumor Quantification in Prostate Core Needle Biopsy Images Using Deep Neural Networks and Its Comparison with Pathologist-Based AssessmentHan Suk Ryu, Min-Sun Jin, Jeong Hwan Park, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 23, 2016
Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancerSu Hyun Lee, Seunggyun Ha, Hyun Joon An, et al.
Pageof 15

Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
International Journal of Molecular Sciences|November 11, 2022
Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning AlgorithmHyebin Lee, Han Suk Ryu, Hee Chul Park, et al.
International Journal of Molecular Sciences|January 27, 2024
Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive SystemIoannis S Pateras, Ana Igea, Ilias P Nikas, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2024
Immune marker expression and prognosis of early breast cancer expressing HER3Dae-Won Lee, Han Suk Ryu, Ilias P Nikas, et al.
Breast Cancer Research and Treatment|September 7, 2022
Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapySong Yi Park, Koung Jin Suh, Dae-Won Lee, et al.
Breast Cancer Research : BCR|November 26, 2020
Combined the SMAC mimetic and BCL2 inhibitor sensitizes neoadjuvant chemotherapy by targeting necrosome complexes in tyrosine aminoacyl-tRNA synthase-positive breast cancerKyung-Min Lee, Hyebin Lee, Dohyun Han, et al.
Scientific Reports|April 14, 2021
Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypassMark Borris D Aldonza, Roben D Delos Reyes, Young Seo Kim, et al.
Genome Biology|October 10, 2018
PHLI-seq: constructing and visualizing cancer genomic maps in 3D by phenotype-based high-throughput laser-aided isolation and sequencingSungsik Kim, Amos Chungwon Lee, Han-Byoel Lee, et al.
Virchows Archiv : an International Journal of Pathology|May 18, 2016
Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancerMin-Sun Jin, Hyebin Lee, In Ae Park, et al.
Cancers|November 27, 2019
Automated Gleason Scoring and Tumor Quantification in Prostate Core Needle Biopsy Images Using Deep Neural Networks and Its Comparison with Pathologist-Based AssessmentHan Suk Ryu, Min-Sun Jin, Jeong Hwan Park, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 23, 2016
Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancerSu Hyun Lee, Seunggyun Ha, Hyun Joon An, et al.
Pageof 15